keyword
https://read.qxmd.com/read/38249869/pleural-fluid-soluble-fas-ligand-and-tuberculous-pleural-effusion-a-prospective-diagnostic-test-accuracy-study
#21
JOURNAL ARTICLE
Xu-Hui Wen, Jian-Xun Wen, Lan Mu, Xi-Shan Cao, Li Yan, Jin-Hong Huang, Hong Chen, Ting-Wang Jiang, Zhi-De Hu, Yan Niu, Wen-Qi Zheng
BACKGROUND: The diagnosis of tuberculous pleural effusion (TPE) is challenging for pulmonologists. Adenosine deaminase (ADA), interferon-gamma (IFN-γ), and interleukin-27 (IL-27) have some limitations for diagnosing TPE. Soluble Fas ligand (sFasL) had a high diagnostic value for TPE. However, it remains unknown: (I) whether sFasL has an additional diagnostic value to the traditional markers (e.g., ADA); (II) whether sFasL provides a net benefit in patients with undiagnosed pleural effusion; (III) factors affecting the diagnostic accuracy of sFasL for TPE...
December 30, 2023: Journal of Thoracic Disease
https://read.qxmd.com/read/38219170/correlation-of-lymphocyte-subsets-and-inflammatory-biomarkers-with-disease-severity-in-covid-19-patients
#22
JOURNAL ARTICLE
Khawar Abbas, Wajiha Musharraf, Mirza Naqi Zafar, Jawahar Lal, Sunil Dodani, Syed Adibul Hasan Rizvi
OBJECTIVE: To determine the correlation of lymphocyte subsets and soluble serum inflammatory biomarkers with disease severity in coronavirus disease-2019 infection. METHODS: The retrospective study was conducted at the Department of Immunology, Sindh Institute of Urology and Transplantation (SIUI), Karachi, Pakistan from September 1 to November 30, 2021, and comprised data of patients admitted from June to July 2021 who tested positive for coronavirus disease-2019 on the basis of reverse transcription-polymerase chain reaction of nasopharyngeal swab specimens...
January 2024: JPMA. the Journal of the Pakistan Medical Association
https://read.qxmd.com/read/38163976/-predictive-value-of-peripheral-blood-biomarkers-in-the-treatment-of-%C3%A2-lung-cancer-patients-with-anti-pd-1-immunotherapy
#23
JOURNAL ARTICLE
Shu Su, Xin Lv, Liang Qi, Min Wei, Baorui Liu, Lifeng Wang
BACKGROUND: The application of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) antibodies has greatly improved the clinical outcomes of lung cancer patients. Here, we retrospectively analyzed the efficacy of PD-1 antibody therapy in locally advanced non-surgical or metastatic lung cancer patients, and preliminarily explored the correlation between peripheral blood biomarkers and clinical responses. METHODS: We conducted a single center study that included 61 IIIA-IV lung cancer patients who received PD-1 antibody treatment from March 2020 to December 2021, and collected the medical record data on PD-1 antibody first-line or second-line treatment...
January 2, 2024: Zhongguo Fei Ai za Zhi, Chinese Journal of Lung Cancer
https://read.qxmd.com/read/38161192/immunostimulatory-nanoparticles-delivering-cytokines-as-a-novel-cancer-nanoadjuvant-to-empower-glioblastoma-immunotherapy
#24
JOURNAL ARTICLE
Flávia Sousa, Henry Lee, Mauro Almeida, Amelie Bazzoni, Barbara Rothen-Rutishauser, Alke Petri-Fink
Glioblastoma (GBM) stands as a highly aggressive and deadly malignant primary brain tumor with a median survival time of under 15 months upon disease diagnosis. While immunotherapies have shown promising results in solid cancers, brain cancers are still unresponsive to immunotherapy due to immunological dysfunction and the presence of a blood-brain barrier. Interleukin-12 (IL-12) emerges as a potent cytokine in fostering anti-tumor immunity by triggering interferon-gamma production in T and natural killer cells and changing macrophages to a tumoricidal phenotype...
December 31, 2023: Drug Delivery and Translational Research
https://read.qxmd.com/read/38149532/bioinformatic-approach-for-repurposing-immunomodulatory-drugs-for-lepromatous-leprosy
#25
JOURNAL ARTICLE
Gary J Espitia, Nelson Enrique Arenas, Luz Dary Gutiérrez-Castañeda, Martha Inírida Guerrero
BACKGROUND: The lepromatous leprosy (LL) disease is caused by Mycobacterium leprae and Mycobacterium lepromatosis which is characterized by inadequate response to treatment, a propensity to drug resistance, and patient disability. We aimed to evaluate current immunomodulatory medicines and their target proteins collectively as a drug repurposing strategy to decipher novel uses for LL. METHODS: A dataset of human genes associated with LL-immune response was retrieved from public health genomic databases including the Human Genome Epidemiology Navigator and DisGeNET...
2023: International Journal of Mycobacteriology
https://read.qxmd.com/read/38140270/correction-shen-et-al-platelet-activation-and-cytokine-release-of-interleukin-8-and-interferon-gamma-induced-protein-10-after-chadox1-ncov-19-coronavirus-vaccine-injection-vaccines-2023-11-456
#26
Chih-Lung Shen, Tso-Fu Wang, Chao-Zong Liu, Yi-Feng Wu
The authors wish to make the following corrections to this published paper [...].
November 28, 2023: Vaccines
https://read.qxmd.com/read/38109851/a-potential-cure-for-tumor-associated-immunosuppression-by-toxoplasma-gondii
#27
REVIEW
Narges Lotfalizadeh, Soheil Sadr, Solmaz Morovati, Mohammadhassan Lotfalizadeh, Ashkan Hajjafari, Hassan Borji
BACKGROUND: Recently, immunotherapy has become very hopeful for cancer therapy. Cancer treatment through immunotherapy has excellent specificity and less toxicity than conventional chemoradiotherapy. Pathogens have been used in cancer immunotherapy for a long time. The current study aims to evaluate the possibility of Toxoplasma gondii (T. gondii) as a probable treatment for cancers such as melanoma, breast, ovarian, lung, and pancreatic cancer. RECENT FINDINGS: Nonreplicating type I uracil auxotrophic mutants of T...
December 18, 2023: Cancer reports
https://read.qxmd.com/read/38064516/a-prospective-cohort-study-of-zoonotic-cutaneous-leishmaniasis-in-tunisia-clinical-and-immunological-features-and-immune-correlates-of-protection
#28
JOURNAL ARTICLE
Ikbel Naouar, Wafa Kammoun Rebai, Afif Ben Salah, Hind Bouguerra, Amine Toumi, Nabil Belhadj Hamida, Hechmi Louzir, Amel Meddeb-Garnaoui
BACKGROUND: This study aimed to define immunological markers of exposure to L. major parasites and identify correlates of protection against infection. METHODS: We analyzed a cohort of 790 individuals at risk of developing ZCL living in endemic areas with varying L. major infection prevalence. One area had a high infection prevalence indicated by high proportions of leishmanin skin test (LST) positive subjects, while the other areas were recent foci with lower infection prevalence...
December 8, 2023: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38043258/plasma-cytokine-and-growth-factor-response-to-acute-psychosocial-stress-in-major-depressive-disorder
#29
JOURNAL ARTICLE
Jayabhargav Annam, Hanga C Galfalvy, John G Keilp, Norman Simpson, Yung-Yu Huang, Renu Nandakumar, Abigail Byrnes, Kayla Nitahara, Aimee Hall, Barbara Stanley, J John Mann, M Elizabeth Sublette
BACKGROUND: Pro-inflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor (TNF)-α are elevated in response to psychosocial stress; however, less is known about other inflammatory markers. METHODS: We explored response to the Trier Social Stress Test (TSST) of 16 cytokines and growth factors in patients with major depressive disorder (MDD, n = 12) vs. healthy volunteers (HV, n = 16). Outcomes were baseline and post-stress levels estimated by area under the curve (AUCi ) and peak change over 3 timepoints...
November 20, 2023: Journal of Psychiatric Research
https://read.qxmd.com/read/38036985/dominant-negative-biologics-normalise-the-tumour-necrosis-factor-tnf-%C3%AE-induced-angiogenesis-which-exploits-the-mycobacterium-tuberculosis-dissemination
#30
JOURNAL ARTICLE
Kusuma Sai Davuluri, Amit Kumar Singh, Vimal Kumar Yadav, Ajay Vir Singh, Shoor Vir Singh, Devendra Singh Chauhan
BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections...
November 30, 2023: BMC Immunology
https://read.qxmd.com/read/38030380/xtx301-a-tumor-activated-interleukin-12-has-the-potential-to-widen-the-therapeutic-index-of-il-12-treatment-for-solid-tumors-as-evidenced-by-pre-clinical-studies
#31
JOURNAL ARTICLE
Ekta Patel, Natalia V Malkova, David Crowe, Magali Pederzoli-Ribeil, Damiano Fantini, Manoussa Fanny, Hanumantha Rao Madala, Kurt A Jenkins, Oleg Yerov, Justin Greene, Wilson Guzman, Caitlin O'Toole, Jacob Taylor, Rebekah K O'Donnell, Parker Johnson, Bernard B Lanter, Brian Ames, Jia Chen, Sallyann Vu, Hsin-Jung Wu, Susan Cantin, Megan McLaughlin, Yu-Shan S Hsiao, Dheeraj S Tomar, Raphael Rozenfeld, Lakshmanan Thiruneelakantapillai, Ronan C O'Hagan, Benjamin Nicholson, Jennifer O'Neil, Carl Uli Bialucha
Interleukin-12 (IL-12) is a proinflammatory cytokine, that has shown promising anti-tumor activity in humans by promoting the recruitment and activation of immune cells in tumors. However, the systemic administration of IL-12 has been accompanied by considerable toxicity, prompting interest in researching alternatives to drive preferential IL-12 bioactivity in the tumor. Here, we have generated XTX301, a tumor-activated IL-12 linked to the human Fc protein via a protease cleavable linker that is pharmacologically inactivated by an interleukin-12 receptor subunit beta 2 (IL-12Rβ2) masking domain...
November 30, 2023: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38025181/dendritic-cell-based-immunity-screening-of-dendritic-cell-subsets-in-breast-cancer-bearing-mice
#32
JOURNAL ARTICLE
Alia M Aldahlawi, Kawther Sayed Ali Zaher
BACKGROUND: Breast cancer (BC) is the most devastating disease, particularly the lethal invasive form. It is the most underlying cause of death among women worldwide. The expansion of BC is controlled by a variety of alterations in the tumor cells themselves, in addition to the state of the immune system, which has a direct influence on the tumor microenvironment. Numerous receptors expressed by T-cells interact with ligands on antigen-presenting cells to provide activation signals results in mounting effector anti-tumor T-cell responses...
2023: Journal of Microscopy and Ultrastructure
https://read.qxmd.com/read/37986911/targeting-gd2-positive-refractory-resistant-neuroblastoma-and-osteosarcoma-with-anti-cd3-x-anti-gd2-bispecific-antibody-armed-t-cells
#33
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana L Schalk, Amy Schienshang, Sara Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony Shields, Nai-Kong Cheung, Lawrence G Lum
Background : Since treatment of neuroblastoma (NB) with anti-GD2 monoclonal antibodies provides a survival benefit in children with minimal residual disease and our preclinical study shows that anti-CD3 x anti-GD2 bispecific antibody (GD2Bi) armed T cells (GD2BATs) were highly cytotoxic to GD2+ cell lines, we conducted a phase I/II study in recurrent/refractory patients to establish safety and explore the clinical benefit of GD2BATs. Methods: The 3+3 dose escalation study (NCT02173093) phase I involved 9 evaluable patients with NB (n=5), osteosarcoma (OST) (n=3), and desmoplastic small round cell tumors (DSRCT) (n=1) with twice weekly infusions of GD2BATs at 40, 80, or 160 x 10 6 GD2BATs/kg/infusion with daily interleukin 2 (300,000 IU/m 2 ) and twice weekly granulocyte-macrophage colony stimulating factor (250 µg/m 2 )...
November 9, 2023: Research Square
https://read.qxmd.com/read/37969879/the-prognostic-utility-of-cytokines-in-hospitalized-covid-19-patients
#34
JOURNAL ARTICLE
Ákos Vince Andrejkovits, Adina Huțanu, Ervin József Susányi, Valentina Negrea, Anca Meda Văsieșiu
INTRODUCTION: The severity of COVID-19 relies on several factors, but the overproduction of pro-inflammatory cytokines remains a central mechanism. The aim of this study was to investigate the predictive utility of interleukin (IL)-6, IL-8, IL-10, IL-12, tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) measurement in patients with COVID-19. MATERIAL AND METHODS: We prospectively enrolled 181 adult patients with COVID-19 admitted to the 1st Infectious Disease County Hospital Târgu Mureș from December 2020 to September 2021...
October 2023: Journal of Critical Care Medicine
https://read.qxmd.com/read/37965256/-ex-vivo-and-in-vivo-evidence-that-cigarette-smoke-exposed-t-regulatory-cells-impair-host-immunity-against-mycobacterium-tuberculosis
#35
JOURNAL ARTICLE
Xiyuan Bai, Deepshikha Verma, Cindy Garcia, Ariel Musheyev, Kevin Kim, Lorelenn Fornis, David E Griffith, Li Li, Nicholas Whittel, Jacob Gadwa, Tamara Ohanjanyan, Matthew J Eggleston, Manuel Galvan, Brian M Freed, Diane Ordway, Edward D Chan
INTRODUCTION: A strong epidemiologic link exists between cigarette smoke (CS) exposure and susceptibility to tuberculosis (TB). Macrophage and murine studies showed that CS and nicotine impair host-protective immune cells against Mycobacterium tuberculosis (MTB) infection. While CS and nicotine may activate T regulatory cells (Tregs), little is known about how CS may affect these immunosuppressive cells with MTB infection. METHODS: We investigated whether CS-exposed Tregs could exacerbate MTB infection in co-culture with human macrophages and in recipient mice that underwent adoptive transfer of Tregs from donor CS-exposed mice...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/37957274/an-immunomodulating-peptide-with-potential-to-suppress-tumour-growth-and-autoimmunity
#36
JOURNAL ARTICLE
Michael Agrez, Christopher Chandler, Kristofer J Thurecht, Nicholas L Fletcher, Feifei Liu, Gayathri Subramaniam, Christopher B Howard, Benjamin Blyth, Stephen Parker, Darryl Turner, Justyna Rzepecka, Gavin Knox, Anastasia Nika, Andrew M Hall, Hayley Gooding, Laura Gallagher
Cancers and autoimmune diseases commonly co-exist and immune checkpoint inhibitor therapy (ICI) exacerbates autoimmune pathologies. We recently described a lipidic peptide, designated IK14004, that promotes expansion of immunosuppressive T regulatory (Treg) cells and uncouples interleukin-2 from interferon-gamma production while activating CD8+ T cells. Herein, we report IK14004-mediated inhibition of Lewis lung cancer (LLC) growth and re-invigoration of splenocyte-derived exhausted CD4+ T cells...
November 13, 2023: Scientific Reports
https://read.qxmd.com/read/37950091/cytokine-profile-in-lambs-naturally-infected-with-sheeppox-virus
#37
JOURNAL ARTICLE
Emin Karakurt, Nuvit Coskun, Enver Beytut, Serpil Dag, Volkan Yilmaz, Hilmi Nuhoglu, Ayfer Yildiz, Emre Kurtbas
In this study, in order to reveal the immune response against the disease in naturally infected sheep with SPPV, the expressions of various pro- or anti-inflammatory cytokines such as tumour necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interleukin-1beta (IL-1β), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10) and interleukin-12 (IL-12) were evaluated immunohistochemically. The material of this study consisted of tissue samples taken from 24 sheep, which were brought as dead for routine histopathological examination to the Department of Pathology...
November 10, 2023: Tropical Animal Health and Production
https://read.qxmd.com/read/37897869/porcine-digestible-peptides-as-alternative-protein-source-in-weaner-diets-effects-on-performance-and-systemic-cytokine-profile-in-pigs-followed-from-weaning-to-slaughter
#38
JOURNAL ARTICLE
A Middelkoop, S Segarra, F Molist
Porcine digestible peptides (PDP) are high-quality hydrolysed proteins obtained from porcine intestinal mucosa as a by-product of the heparin manufacturing process. PDP contain bioactive peptides and are used as alternative protein sources in several animal species, including pigs. We aimed to explore the (carry-over) effects of feeding PDP to weaned piglets on performance and systemic cytokine levels of pigs followed until slaughter. A total of 192 piglets were allocated to one of two dietary treatments: control (CON) or PDP weaner diets...
September 29, 2023: Animal
https://read.qxmd.com/read/37883350/circulating-inflammatory-cytokines-and-psoriasis-risk-a-systematic-review-and-meta-analysis
#39
JOURNAL ARTICLE
Xiao-Qing Liu, Pei-Lin Zhou, Xin-Yu Yin, Ai-Xue Wang, Da-Hu Wang, Yun Yang, Qiang Liu
BACKGROUND: Psoriasis is a systemic immune-mediated chronic inflammatory skin disease; its systemic manifestations and periodic recurrence negatively affect a patient's quality of life. Inflammatory cytokines are known to have an important role in the onset and progression of psoriasis, however, data on the association between circulating inflammatory cytokines and psoriasis risk is inconclusive. Here, we explore the relevance of circulating proinflammatory factors to the pathogenesis of psoriasis using a meta-analysis...
2023: PloS One
https://read.qxmd.com/read/37876509/biomarkers-of-ocular-allergy-and-dry-eye-disease
#40
JOURNAL ARTICLE
Mihail Zemba, Mihai-Alexandru Ionescu, Ruxandra Angela Pîrvulescu, Otilia-Maria Dumitrescu, Brănişteanu Daniel-Constantin, Mădălina Radu, Alina-Cristina Stamate, Sînziana Istrate
The most common disorders of the ocular surface are dry eye disease (DED) and ocular allergy (OA). These conditions are frequently coexisting with or without a clinical overlap and can cause a severe impact on the patient's quality of life. Therefore, it can sometimes be hard to distinguish between DED and OA because similar changes and manifestations may be present. Atopic patients can also develop DED, which can aggravate their manifestations. Moreover, patients with DED can develop ocular allergies, so these two pathological entities of the ocular surface can be considered as mutual conditions that share the same background...
2023: Romanian Journal of Ophthalmology
keyword
keyword
45659
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.